Epic Sciences
UEI: D5C7DHKSU7H9
• CAGE: 5DCQ6
Overview
Awardee Type
Parent
Company Description
Epic Sciences develops clinical solutions that accelerate drug development and guided therapy across cancer drug indications. Epic's new AR-V7 CTC liquid biopsy test is the first clinically proven predictive test for metastatic castration-resistant prostate cancer.
Name
Epic Sciences
Website
Headquarters
San Diego, CA
United States
United States
Most Recent Award
Sept. 11, 2019
Calculating
Federal contract recipient
EPIC SCIENCES, INC.
dba EPIC SCIENCES INC
(UEI D5C7DHKSU7H9, CAGE 5DCQ6)
is headquartered in San Diego CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in September 2008 and
federally registered in
March 2009.
Federal Award Analysis
Epic Sciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
EPIC SCIENCES, INC.
DBA
EPIC SCIENCES INC
UEI
D5C7DHKSU7H9
CAGE Code
5DCQ6
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 3, 2008
Initial Registration
March 24, 2009
Last Registration
July 6, 2024
Registration Activation
July 11, 2023
Registration Expiration
July 6, 2024
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No